Related Experiment Video

Updated: Sep 8, 2025

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
09:38

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on: June 26, 2019

8.0K

Response to "The Afatinib Response to EGFR E709G-mutated Lung Cancer"

Sangeetha Isaac1, Misbah Qadir1

  • 1Hematology & Oncology, East Carolina University, USA.

Internal Medicine (Tokyo, Japan)
|August 13, 2025
PubMed
Abstract

No abstract available in PubMed .

Keywords:
AfatinibEGFR mutationLung cancer

More Related Videos

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
09:38

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure

Published on: August 11, 2017

8.9K
Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
08:52

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on: November 22, 2021

4.2K

Related Experiment Videos

Last Updated: Sep 8, 2025

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
09:38

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on: June 26, 2019

8.0K
Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
09:38

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure

Published on: August 11, 2017

8.9K
Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
08:52

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on: November 22, 2021

4.2K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K

Articles linked to this work by shared authors, journal, and citation graph.

Antibody-Drug Conjugates in the Management of Breast Cancer.

Southern medical journal·2026

Efficacy and safety of trastuzumab deruxtecan in gastrointestinal malignancies: a systemic review and meta-analysis.

Frontiers in gastroenterology (Lausanne, Switzerland)·2026

Managing a Rare Case of Mixed Extrapulmonary Small Cell Carcinoma and Adenocarcinoma of the Prostate.

Cureus·2023

Role of the PLASMIC Score in the Management of Thrombotic Thrombocytopenic Purpura.

Cureus·2023

Pulmonary Cryptococcosis and Pulmonary Fibrosis: A Complication of COVID-19 Pneumonia.

Cureus·2023

Potential Role of High-Dose Steroids in the Treatment of COVID-19-Associated Nephropathy.

Cureus·2023

Life Course Immunization in Japan: A Practice-Oriented Framework for Internal Medicine.

Internal medicine (Tokyo, Japan)·2026

Contemporary Guideline Perspectives on Methotrexate and Biologic/Targeted Synthetic Disease-Modifying Antirheumatic Drugs (DMARDs) in Rheumatoid Arthritis-Associated Interstitial Lung Disease.

Internal medicine (Tokyo, Japan)·2026

Esophageal cancer-associated thoracic central venous obstruction type 2 which occurred during chemoradiotherapy.

Internal medicine (Tokyo, Japan)·2026

Gastrointestinal Diseases and Sarcopenia.

Internal medicine (Tokyo, Japan)·2026

Chronic Kidney Disease with Sjögren's Syndrome and Hyperthyroidism: Discrepant Creatinine- and Cystatin C-Based eGFR.

Internal medicine (Tokyo, Japan)·2026

Coexistent IgG4-Related Sclerosing Cholecystitis and Xanthogranulomatous Cholecystitis in the Gallbladder: A Case Report.

Internal medicine (Tokyo, Japan)·2026

An integrated multiscale air quality modelling framework for industrial park pollution: Linking local emissions to regional transport.

Journal of environmental sciences (China)·2026

Face mask littering: environmental impacts, regulatory challenges, and AI-driven waste management strategies for the postpandemic era.

Turkish journal of medical sciences·2026

Environmental impact of NanoNeedle arthroscopy versus conventional knee arthroscopy: a hybrid carbon footprint analysis.

BMJ open·2026

Advancing Long-Term Outdoor Air Pollution Exposure Assessment for Health Studies: Lessons from a Multinational Research Initiative.

Current environmental health reports·2026

Retrograde intubation as a rescue strategy in a patient with distorted laryngeal anatomy after tracheal resection and anastomosis: A case report.

Journal of perioperative practice·2026

[Analysis and Prediction of the Zero-carbon Park Initiative in Anhui Jieshou High-tech Industrial Development Zone].

Huan jing ke xue= Huanjing kexue·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us